Amid ongoing controversy over clinical trial transparency, a new analysis found that just 3% of the more than 3,700 studies run exclusively in Canada over a recent 10-year period were registered prospectively, reported results, and published the findings.
More specifically, 47% of those trials, or more than 1,770, were registered in advance, while only 12% reported results in a registry and 48% published their findings. The analysis examined trials that were completed between 2009 and 2019.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
